The insertion of suicide genes in donor T lymphocytes constitutes the basis of new approaches aiming at the treatment of the graft-versus-host disease (GVHD), a frequent complication in recipients of allogeneic haematopoietic grafts. In this study we investigated the impact that the ex vivo manipulation required for the retroviral transduction of T cells had on the functionality and differentiation of these cells. Compared to fresh T cells, samples that had been subjected to standard activation (1 mg/ml of both antiCD3i and anti-CD28i MoAbs) followed by transduction with vectors encoding for the HSV-tk and tNGFR genes maintained the proliferative response to an allogeneic stimulus. These cells, however, had a significantly lower cytotoxic response to allogeneic cells compared to fresh samples. When the concentration of anti-CD3i was reduced to up to 1000-fold (1 ng/ml), similar T-cell transductions were obtained, while the cytotoxicity of the ex vivo manipulated samples was significantly recovered, when assessed either at 7 or 14 days of culture. In all instances, a similar functionality was observed in transduced samples not subjected to immunomagnetic cell sorting, compared to purified fractions enriched in NGFR þ and NFGR À cells. The analysis of CD45RA and CCR7 markers in samples transduced under standard stimulatory conditions showed a differentiation of fresh CD8 þ CD45RA þ /CCR7 þ naive cells to cells having a predominant central CD45RA À /CCR7 þ and effector CD45RA À /CCR7
À memory phenotype. However, when samples were activated with low doses of anti-CD3i, a significant population of naive cells became apparent. Although activation with high doses of anti-CD3i/anti-CD28i resulted in a similar phenotype in both NGFR þ and NFGR À populations, the naive population observed in samples activated with low concentrations of anti-CD3i was almost restricted to the NGFR À population. These results show that reducing the stimulation mediated by anti-CD3i in protocols of T-cell retroviral gene transfer significantly helps to preserve the cytotoxic capacity of these cells to allogeneic cells, without affecting the susceptibility of these cells to the retroviral vector. In addition, we observed that modulating the activation of transduced T cells implies the generation of changes in the differentiation of CD8 þ cells, although we
Introduction
In the setting of allogeneic stem cell transplantation, graft-versus-host-disease (GVHD) is a frequent complication that can threaten the patient's life. 1, 2 A majority of these patients receive immunosuppressive treatments or, eventually, T-cell-depleted grafts, but these approaches increase the risk of engraftment failures, viral infections and relapses of the original malignant disease. [3] [4] [5] Added to their involvement in GVHD, T cells present in the graft also participate in a graft-versus-leukaemia effect (GVL), contributing to the elimination of residual malignant cells. 6 The use of suicide genes, such as the thymidine kinase from the Herpes Simplex virus (HSV-tk), constitutes a new tool for the management of the GVHD. The transduction of T lymphocytes with this gene turns them susceptible to ganciclovir, allowing the selective elimination of donor T lymphocytes in patients who develop severe episodes of GVHD [7] [8] [9] [10] [11] [12] In previous studies, we investigated the relevance that several biological parameters had on the generation of human T cells bearing and expressing a transgene of interest. 13 The transduction process included a first step for activating the proliferation of peripheral blood T lymphocytes, a second process of retroviral infection and, finally, a period to facilitate the expression of the selectable transgene. A number of studies support that the ectopic expression of marker transgenes is significantly improved when transduced cells are stimulated with both immobilized anti-CD28 (anti-CD28i) and antiCD3i antibodies. [13] [14] [15] Our results showed that both the transduction efficacy and the total number of transduced T cells can be optimized when both preinfected and postinfected T cells are activated with anti-CD3i/antiCD28i MoAbs. 13 Since a critical aspect for the adoptive transfer of transduced T lymphocytes is the immunocompetence of these populations, several studies have investigated the generation of changes in the functionality of transduced grafts as a result of the in vitro manipulation of the samples. A reduced diversity of the T-cell receptor repertoire 12, 16 and a reduced clonogenicity 17 have been observed in T lymphocytes subjected to relatively longterm incubation periods. In addition, a number of studies have shown that PHA-activated lymphocytes display an impaired response to allogeneic stimulation. 18 Also impaired antiviral-specific responses have been described for T lymphocytes activated with anti-CD3. 19 In some instances, the addition of anti-CD28 partially prevented the repertoire skewing of T-cell populations, as well as the activation-induced death of these cells. 12, 19, 20 Moreover, additional studies have demonstrated that in the presence of an antigen signal, engagement of CD28 -either by specific antibodies or its natural ligands B7-1 and B7-2 -increases the antigenspecific proliferation and the production of cytokines. This promoted the induction of T-cell survival signals by bcl-xL. 21, 22 All these results suggest that the inclusion of anti-CD28i to anti-CD3i activation may be of critical relevance for preserving the functionality of T cells during in vitro cell manipulations. 23 In addition to the in vitro studies, the infusion of T cells previously subjected to in vitro activation showed a reduced GVHD in allogeneic recipients, compared to reactions mediated by fresh T cells. This reduced alloreactivity was attributed to activation effects and increased sensitivity to apoptosis. [24] [25] [26] [27] In the current study we have investigated the impact that the activation, the retroviral infection and the selection of transduced cells had on the functionality of human T lymphocytes. With this purpose, we have analysed the proliferative and cytotoxic response of fresh and transduced T cells after exposures to an allogeneic stimulus. In addition, the relevance that the intensity of T-cell stimulation had in the differentiation and functional capabilities of transduced T cells has been investigated.
Results and discussion
Analysis of the proliferation response of fresh and retrovirally transduced human T lymphocytes
To investigate the proliferation response of fresh and transduced T cells to IL-2, fresh peripheral blood mononuclear cells (PBMNCs) or samples that had been subjected to standard retroviral transduction 13 were maintained in the presence of 100 U/ml of IL-2. As expected, transduced samples showed a proliferation response to IL-2 significantly higher than that observed Retroviral-mediated human T-cell transduction ML Lamana et al in fresh T cells (Figure 1 ). In addition, we observed that the IL-2 proliferation response was significantly higher in samples that had been subjected to transduction under standard stimulatory conditions (1 mg/ml anti-CD3i/ anti-CD28i) compared to those activated with 1 mg/ml anti-CD3i (Figure 1a ). Since previous studies showed that cell selection could alter the functionality -including the GVHD reactivity -of transduced cells, 17, 19, 28 we have investigated whether or not the immunomagnetic cell sorting of cells expressing the selectable tNGFR transgene modifies the proliferative response of T cells to IL-2. The experiments in Figure 1b show that no differences in the proliferative response of T cells to IL-2 were observed between transduced unselected cells with respect to the NGFR þ (96% NGFR þ ) and NGFR À (o10% NGFR þ ) fractions collected after immunoselection.
To investigate whether the transduction process changed the proliferation response of T cells to an allogeneic stimulus, fresh T cells and T cells subjected to the transduction process were co-cultured with five different unrelated and irradiated allogeneic PBMNCs in the absence of IL-2. As shown in Figure 1c , a similar proliferation rate was observed in the fresh and the ex vivo manipulated lymphocytes, regardless of whether anti-CD3i or anti-CD3i/anti-CD28i were used for cell activation. Consistent with IL-2 stimulation studies ( Figures 1a and b) , the proliferation response of ex vivo manipulated cells to an allogeneic stimulus was similar regardless of whether cells were subjected to immunomagnetic cell sorting or not. Again, similar proliferation responses were found in the positive (95% NGFR þ ) and negative (o10% NGFR þ ) fractions after immunomagnetic selection (Figure 1d ).
Taken together, these data show that the retroviral transduction of human T cells -including the activation processes required for the integration and expression of the transgene -sensitized the proliferation response of the cells to a nonspecific IL-2 stimulus and maintained unchanged its response to an allogeneic stimulation. In addition, these results show that neither the cell sorting process nor the transduction/expression of the transgene modified the proliferative response of gene-modified samples not subjected to cell selection.
Cytotoxic response of human transduced T lymphocytes exposed to an allogeneic stimulus
In a next set of experiments, the immunocompetence of transduced lymphocytes was studied by testing their cytolytic activity against an allogeneic stimulus. In the experiments shown in Figure 2 , we quantified the MHCmediated cytotoxicity activity both in fresh and in transduced samples after incubation with different effector:target ratios. As shown in Figure 2a , the cytotoxic response of cells subjected to the transduction process was significantly lower than that observed in fresh T cells. As observed in the allogeneic proliferative analyses (Figure 1 ), no significant difference in the cytotoxic response was observed between transduced samples that had been activated with anti-CD3i or antiCD3i/anti-CD28i (Figure 2a ). Additionally, in some preliminary experiments, controls with activated but noninfected cells were performed, and no difference was found between the cytotoxicity of this population compared to that seen in cells that underwent the whole transduction procedure (data not shown). These results show that, at least under our experimental conditions, the addition of anti-CD28i to anti-CD3i stimulation does not improve the cytotoxic response of the transduced samples, as previously shown for a number of antiEpstein-Barr virus responses. 19 To confirm these observations with immunoselected cells, transduced samples that had been activated with anti-CD3i/anti-CD28i were subjected to immunomagnetic cell sorting. As shown in Figure 2b , the same cytolytic activity was observed in unselected cells, compared to that observed in the NGFR þ (95% NGFR þ ) and NGFR À (13% NGFR þ ) purified fractions. In a recent study, a similar reduced cytotoxicity has been reported for NGFR transduced lymphocytes, although changes in the cytotoxicity of the transduced samples were observed after long periods of T-cell culture. 29 These data show that the MHC-dependent cytolytic activity of CD8 þ lymphocytes was significantly impaired as a result of the ex vivo manipulation of the sample. Moreover, our results showing that the unselected cells and the positive and negative MACS-selected fractions presented a similar cytolytic activity demonstrate that neither the immunoselection process nor the insertion/expression of the marker transgene accounts for the reduced cytolytic activity observed in the ex vivo manipulated cells. Therefore, the most plausible cause accounting for the reduced cytolytic capacity observed in T cells subjected to retroviral transduction should be related to the in vitro stimulation of these cells.
From these first sets of experiments, a clear discrepancy between the proliferative and the cytotoxic capacity of transduced cells is demonstrated. This fact could indicate a possible difference in the functionality of anti-CD3i/anti-CD28i-activated CD4 þ and CD8 þ cells. In this respect, previous studies showed that CD8 Previous studies have shown that cell proliferation is a prerequisite to facilitate the integration of oncoretroviral vectors in infected cells. 31 On the basis of this observation, and given that an impaired functionality of T cells has been previously related to the stimulation of T-cell samples, 18 we have now investigated whether by lowering the concentration of anti-CD3i during T-cell stimulation we could preserve both the susceptibility of the cells to retroviral transduction and also their cytolytic response to an allogeneic stimulus. The experiments shown in Figure 3 demonstrate that lowering the dose of anti-CD3i from the standard 1 mg/ml concentration to up to 0.1 ng/ml did not significantly modify the transduction of human T cells (P40.5 between all the paired samples studied). In addition, only slight, though not significant, reduction in the total number of transduced T cells was generated when samples were stimulated with doses as low as 0.1 ng/ml of anti-CD3i (P40.1 between all the paired samples studied in the range of 1 mg-0.1 ng/ml anti-CD3i; P40.5 in the range of 1 mg-1 ng/ml). Similar results were obtained when cells were maintained for 7 additional days in culture (data not shown).
On the basis of these results, we investigated the cytotoxic response to an allogeneic stimulus of transduced T cells maintained in the presence of low concentrations of anti-CD3i. Human T cells were thus transduced under standard activation and expansion conditions (1 mg/ml of anti-CD3i plus anti-CD28i) but using only 1 ng/ml anti-CD3i plus 1 mg/ml anti-CD28i. As before, a fraction of cells exposed to retroviral supernatants were subjected to immunomagnetic cell sorting for analysing the cytotoxicity of purified populations of NGFR þ and NGFR À cells. As shown in two representative experiments (Figures 4a and b) , the cytotoxic activity of the NGFR þ fraction (495% NGFR þ ) of ex vivo-manipulated T cells that had been activated with a low dose of anti-CD3i was significantly higher -although still subnormal -compared to that observed in cells activated under standard conditions (1 mg/ml) (Po0.05 in the analyses of E:T 20:1 data from three different experiments). Similar conclusions were obtained in NGFR À -purified (o9% NGFR þ ; see Figure  4b ) and non-NGFR-purified (data not shown) populations.
Since in the clinical setting, a 1-week incubation period may generate a limited amount of transduced T cells to be infused in a patient, we aimed to confirm our observations in transduced samples that were maintained for 2 weeks in culture. This period allowed us to generate from 2 to 3.6 times more of transduced T cells compared to expansion periods of 1 week, a number that is clearly compatible with infusions of around 10 7 transduced T cells/kg. The results shown in Figure 5 show that, as observed on day 7 post-infection, the cytotoxic function of transduced T cells that were expanded for 2 weeks in the presence of low concentrations of anti-CD3i laid between that observed in fresh and in cultured T cells subjected to stimulation with high doses of anti-CD3i. As before, we found that this observation was true both in non-NGFR-purified ( Figure  5a ) and in NGFR þ and NGFR À fractions (Figure 5b ) (Po0.05 in the analyses of E:T 20:1 data from three different experiments). A comparable functionality of 
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fresh and CD8 þ cells activated with anti-CD28i plus 0.5 mg/ml of anti-CD3i has been recently reported. 18 The re-stimulation of T cells after transduction that is employed in our protocol could explain this discrepancy due to a possible decrease in the response of CD8 þ cells after a new stimulus.
To investigate whether differences in the proportion of CD4 þ and CD8 þ subpopulations generated under low and high stimulatory conditions could account for the differences in cytotoxicity, the relative presence of these cells in cultures subjected to both activation protocols was determined. As shown in a representative experiment illustrated in Figure 6 , the use of the different activation protocols did not have any relevant impact in the proportion of CD4 þ and CD8 þ cells generated at the end of the incubation, either when analysed at day 7 or at day 14 of expansion.
These results indicate that reducing the dose of antiCD3i up to 1000-fold does not affect the susceptibility of these cells to retroviral transduction and improves, although not normalizes, the cytotoxic response of transduced T cells to an allogeneic stimulus. In addition, and in consistency with our data in Figure 3 , we conclude that changes in the cytotoxic response of the transduced T cells were more dependent on the intensity of stimulation rather than on the insertion/expression of the transgene, and were not directly related to changes in the proportion of CD4 þ and CD8 þ subpopulations generated along the culture. Whether or not the number of antigen-presenting cells (APC) in fresh populations with respect to samples subjected to different levels of activation, and/or the re-stimulation of T cells after transduction account for our observations should be further investigated.
Influence of the in vitro stimulation of human T cells on the differentiation of transduced human T cells
Given that the expression of the chemokine receptor CCR7 and the memory marker CD45RA has been proposed to characterize the differentiation and functionality of human T cells 32, we investigated whether the improved T-cell cytotoxic response, associated to stimulation with low doses of anti-CD3i, correlated with changes in the CCR7/CD45RA phenotype of T-cell populations. In consistency with earlier studies, 32 fresh CD8 þ cells contained a higher proportion of CD45RA þ / CCR7 þ naive cells. When samples were subjected to retroviral transduction under standard stimulatory þ /CCR7 þ phenotype (Figure 7 ). Lowering the concentration of anti-CD3i down to 1000-fold (1 ng/ml) implied that the population of naive cells (CD45RA þ / CCR7 þ ) generated at the end of the transduction process increased to around 20% (see Figure 7) . These results are consistent with previous reports indicating that the polyclonal stimulation mediated by CD3i/CD28i can reproduce the differentiation steps defined by antigen-specific stimulation. 32, 33 Additionally, our data indicate that this process can be modulated by the strength of the in vitro polyclonal stimulus.
To investigate whether these observations were true both for transduced NGFR þ cells and for cells not expressing the NGFR transgene, transduced samples that had been activated with different concentrations of anti-CD3 were subjected to immunomagnetic cell sorting, and then analysed for the expression of CD45RA and CCR7 markers. When NGFR À (o9%NGFR þ ) cells were analysed, a similar differentiation pattern to that observed in unsorted cells (Figure 7 ) was observed. Essentially this is summarized by a progressive increase in the proportion of naive CD45RA þ /CCR7 þ T cells as the dose of antiCD3i was reduced (Figure 8) . In contrast to this observation, when NGFR þ (495% NGFR þ ) cells were analysed, the proportion of naive CD45RA þ /CCR7 þ cells always remained below 5%, regardless of the antiCD3i dose used for T-cell activation. In this NGFR þ fraction, most cells expressed a central memory CD45RA À /CCR7 À and an effector memory CD45RA
These data thus indicate that the naive population detected in samples subjected to transduction under low anti-CD3i stimulation is almost entirely restricted to NGFR À cells. Given that oncoretroviruses only infect dividing cells, it is conceivable that under reduced stimulatory conditions, slowly dividing cells may retain a naive CD45RA þ /CCR7 þ phenotype, and may result in being partially refractory to the infection. On the contrary, cells present in the NGFR þ fraction -which must have been transduced and which express the marker transgene -predominantly differentiate into memory cells, either central or effector memory cells, regardless of the intensity of stimulation used to facilitate the T-cell transduction and transgene expression. Although earlier studies have demonstrated the possibility of transducing T cells having a CD45RA þ naive phenotype by using IL-7 stimulation, 34 we cannot formally demonstrate in our experiments that naive cells have been transduced under our experimental conditions.
Taken together the cytotoxic responses (Figures 2 and  4 ) and the phenotypic changes (Figures 7 and 8 ) of transduced T lymphocytes subjected to different stimulatory conditions, we observed some discrepancy between both functions. In this respect, while the NGFR þ fraction from populations subjected to high stimulation displayed a similar differentiation profile (essentially central and effector memory cells) compared to samples exposed to low concentrations of anti-CD3i, a consistently higher cytotoxic capacity was observed in NGFR þ cells stimulated with low doses of anti-CD3i. Therefore, although previous studies have shown a number of functional differences depending on the CD45RA/CCR7 phenotype of T cells, 32 our results show significant differences in the functionality of cells having a similar central and effector memory phenotype, particularly with respect to their capacity to respond to an allogeneic Retroviral-mediated human T-cell transduction ML Lamana et al stimulus. In this respect, similar discrepancies between T-cell differentiation and cell function have also been observed when analysing the response of these cells to a viral infection. 33 In summary, our results indicate that in the context of anti-CD3i/anti-CD28i stimulations, reducing the dose of anti-CD3i mediates an improvement in the cytotoxicity of transduced T cells to allogeneic stimulation. We propose that this observation should be taken into account in the design of T-cell transduction protocols in order to preserve the function of these cells in the infused patient, particularly for developing a GVL effect in leukaemia patients.
Materials and methods

Retroviral vectors
The SCFMM-3#35 retroviral vector was used throughout (San Raffaele Biomedical Science Park, Milan, Italy). This vector encodes for the Herpes Simplex thymidine kinase (HSV-tk) gene under the control of the retrovirus LTR promoter, as well as the truncated human low-affinity nerve growth factor receptor (DLNGFR) under the control of the SV40 early promoter. Clinical-grade infective supernatants generated by amphotropic AM12 cells were kindly provided by Molmed (San Raffaele Biomedical Science Park, Milan, Italy).
Retroviral transduction protocol
Human PBMNCs were obtained from healthy volunteers after a Ficoll centrifugation gradient of their peripheral blood. PBMNCs were diluted in RPMI supplemented with 10% of foetal bovine serum (FBS; Bio-Wittaker, Massachusetts, USA), penicillin/streptomycin (50 U/ml; Gibco-BRL, Life Technologies, Scotland), L-glutamine (L-Glu 2 mM; Gibco BRL) and interleukin 2 (IL-2; 150 U/ml; Proleukin, Chiron Iberia, Spain). Activation of the PBMNCs was performed either with immobilized anti-CD3 monoclonal antibody (anti-CD3i; 1 mg/ml, clone OKT3; Ortho Biotech. Inc., New Jersey, USA) alone or combined with immobilized anti-CD28 monoclonal antibody (anti-CD28i; 1 mg/ml, clone CD28.2, Pharmingen, California, USA), for 2-3 days at 371C and 5% CO 2, as previously described. 13, 35, 36 In some experiments, the concentration of anti-CD3i was lowered up to 0.1 ng/ml, maintaining the same 1 mg/ml concentration of antiCD28i.
After this period, cells were placed in wells coated with fibronectin (FN; see below) and infected with supernatants containing the retroviral vector for 4 h at 321C and 5% CO 2 . Half the medium was then replaced with fresh medium, and cultures were incubated overnight at 371C and 5% CO 2 . The same procedure was repeated daily for 2 additional days, completing three infection cycles on 3 consecutive days. On the third day, after the addition of fresh medium, the cells were expanded for 2 additional days, either in anti-CD3i or anti-CD3i/anti-CD28i-coated plates, under the same Retroviral-mediated human T-cell transduction ML Lamana et al conditions as those used for activating fresh PBMNCs. The whole transduction procedure thus lasted 7 days. In some experiments, the expansion period was prolonged for 7 additional days, with a lasting of the total procedure of 14 days. The coating with FN was made by adding 20 mg/cm 2 of the CH-296 fragment (RetroNectin, Takara, Biomedicals, Japan) to non-tissue-culture-treated plates for 2-4 h at room temperature and washed before use. 13 Immunomagnetic selection of NGFR/HSV-TK transduced cells
Where indicated, cells subjected to the whole transduction process were sorted by immunomagnetic selection. Briefly, cells were washed and incubated for 30 min at 41C with a mouse anti-LNGFR-monoclonal antibody (Boehringer Mannheim, Spain). Labelled cells were then washed and incubated with microbeads conjugated to monoclonal rat-anti-mouse IgG1-antibody (Myltenyi Biotech, Germany) for 15 min at 41C. Cells were loaded onto mini-MACS columns and subjected to immunomagnetic selection according to the manufacturer's instructions. NGFR þ and NGFR À fractions were recovered to conduct functional analyses. In all instances, the purity of the positive fraction was above 95% of NGFR þ cells and the percentage of NGFR þ cells in the negative fraction below 10-15%.
Proliferation assay
Transduced cells (nonselected, positive and negative fractions, where indicated), as well as fresh control PBMC from the same healthy donors, were tested for their ability to proliferate in response to rhIL-2 and an allogeneic stimulation. In the IL-2 proliferation studies, lymphocytes (10 4 /well) were cultured in 96-well plates in the presence of 0 and 100 U/ml of rhIL-2 (Eurocetus, Amsterdam, The Netherlands) for 3 days. In the allogeneic-driven proliferation studies, cells were allostimulated in a mixed lymphocyte reaction (MLR) using a panel of five unrelated, 25 Gy irradiated PBMCs for 5-6 days. At 18 h before the end of both cultures, 1mCi/well of methyl-3 H thymidine was added (Amersham Pharmacia, Uppsala, Sweden). Finally, cells were harvested (Tomtec, Orange, USA) and radioactivity was measured in a 1450 Microbeta -Scintillation Counter (Wallac, Turku, Finland). The results are expressed as counts per minute (cpm) and presented as means of each triplicate 7s.d.
Cytotoxic assay
The transduced lymphocytes (responder-effector cells), nonselected and, in some experiments, the positive and negative fraction of the transduced/selected cells, were stimulated by allogeneic peripheral lymphocytes irradiated with 25 Gy (stimulating cells) at a responder to stimulator ratio of 1:1. IL-2 (5 U/ml) was added at days 3, 6 and 9. Target cells were generated from the same allogeneic peripheral lymphocytes 7-10 days before the cytotoxicity analysis, by incubation with 2 mg/ml PHA (Sigma, St Louis, MO, USA) for 3 days and subsequent stimulation with 25 U/ml IL-2. On day 10, these PHA blast target cells were labelled with 51 Cr (10 mCi/ 10 6 cells) for 2 h at 371C and washed twice. Responder/ effector cells and the labelled target cells were plated in triplicate, at the indicated effector to target ratios, in a final volume of 200 ml in a 96-well round-bottom plate. After 4 h of incubation, the supernatants were removed and counted in a gamma counter. Maximal 51 Cr release was achieved by adding 1% of Triton X-100 to the target cells. Cytotoxicity was expressed as a percentage of specific lysis according to the formula (experimental releaseÀspontaneous release/total releaseÀspontaneous release) Â 100, and is presented as means of each triplicate 7s.d.
Flow cytometry analyses
The expression of the truncated NGFR transgene was analysed with an FITC-conjugated anti-NGFR monoclonal antibody (Boehringer Mannheim, Spain). The phenotype of the cells was determined using purified CCR7 (clone 2H4, Beckton Dickinson, California, USA) and a secondary antibody anti-mouse-FITC IgM, and mouse monoclonal antibodies directed against CD45RA, CD3, CD4 and CD8 antigens conjugated with PE, FITC and PC5 (all Immunotech, Coulter Company, France). All antibodies were used following the manufacturer's instructions. Regions were established as o1% of the nonspecific staining. Cells were analysed by cytometry analysis with an EPICS XL flow cytometer (Coulter, Florida, USA).
Statistical analysis
Statistical analyses were performed with the Statgraphics software. Biologic data were compared using the MannWhitney test for paired samples.
